Michael Sarcone
Stock Analyst at Jefferies
(0.40)
# 4,007
Out of 4,754 analysts
5
Total ratings
33.33%
Success rate
-14.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $69.75 | +36.20% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $150.01 | -16.67% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $5.85 | +70.94% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $17.72 | -15.35% | 1 | Nov 11, 2022 | |
| EDAP EDAP TMS | Initiates: Buy | $11 | $2.50 | +340.00% | 1 | Nov 1, 2022 |
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $69.75
Upside: +36.20%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $150.01
Upside: -16.67%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $5.85
Upside: +70.94%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $17.72
Upside: -15.35%
EDAP TMS
Nov 1, 2022
Initiates: Buy
Price Target: $11
Current: $2.50
Upside: +340.00%